...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >PREFERENCES FOR TREATMENT ATTRIBUTES OF DULAGLUTIDE AND LIRAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS AND THEIR WILLINGNESS TO SELF-INJECT DIABETES MEDICATION: A COMPARISON BETWEEN JAPAN AND THE UNITED KINGDOM

【24h】

PREFERENCES FOR TREATMENT ATTRIBUTES OF DULAGLUTIDE AND LIRAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS AND THEIR WILLINGNESS TO SELF-INJECT DIABETES MEDICATION: A COMPARISON BETWEEN JAPAN AND THE UNITED KINGDOM

机译：2型糖尿病患者的DULAGLUIDE和LIRAGLUTIDE的治疗属性及其对糖尿病自我治疗的意愿：日本与英国的比较

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Gelhorn H. L.; Bacci E. D.; Poon J. L.; Boye K. S.; Suzuki S. J.; Babineaux S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. PREFERENCES FOR TREATMENT ATTRIBUTES OF DULAGLUTIDE AND LIRAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS AND THEIR WILLINGNESS TO SELF-INJECT DIABETES MEDICATION: A COMPARISON BETWEEN JAPAN AND THE UNITED KINGDOM [J] . Gelhorn H. L., Bacci E. D., Poon J. L., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：2型糖尿病患者的DULAGLUIDE和LIRAGLUTIDE的治疗属性及其对糖尿病自我治疗的意愿：日本与英国的比较
2. Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies [J] . Shuichi Suzuki, Tomonori Oura, Masakazu Takeuchi, Health and Quality of Life Outcomes . 2017,第1期

机译：评估每周一次度拉鲁肽对日本2型糖尿病患者报告的结局的影响：两项随机研究与利拉鲁肽，甘精胰岛素和安慰剂的比较
3. Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study [J] . Odawara M., Miyagawa J., Iwamoto N., Diabetes, obesity & metabolism . 2016,第3期

机译：在日本2型糖尿病患者中，每周一次胰高血糖素样肽1受体激动剂dulaglutide与每日一次liraglutide相比可显着降低糖化血红蛋白：一项随机III期研究的治疗52周
4. Transition to Adult Care for Youth with Type 1 Diabetes Mellitus: Structured Support Aids for Adolescents and Young Patients in Morioka Area, Japan [C] . Kazuma Takahashi, Akio Takahashi, Yasushi Ishigaki International Conference on eHealth, Telemedicine, and Social Medicine . 2018

机译：与1型糖尿病的青少年过渡到青少年：日本Morioka地区的青少年和年轻患者的结构化支持辅助工具
5. Effect of dosing regimens on medication use, healthcare resource utilization, and costs in Medicaid enrolled type 2 diabetes mellitus patients [D] . Jayawant, Sujata S. 2008

机译：剂量方案对纳入Medicaid的2型糖尿病患者的用药，医疗资源利用和费用的影响
6. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom [O] . Lei Qin, Stephanie Chen, Emuella Flood, 2017

机译：胰高血糖素样肽1受体激动剂的治疗属性对有注射经验的2型糖尿病患者很重要：在德国和英国的偏好研究
7. Preferences For Treatment Attributes Of Dulaglutide And Liraglutide Among Patients With Type 2 Diabetes Mellitus And Their Willingness To Self-Inject Diabetes Medication: A Comparison Between Japan And The United Kingdom [O] . HL Gelhorn, ED Bacci, JL Poon, 2016

机译：2型糖尿病患者的杜拉格葡萄酒和丽格蛋白质治疗属性的偏好及其愿意自我注射糖尿病药物：日本和英国的比较

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号